Publications
Export 21 results:
Filters: Keyword is Microglia [Clear All Filters]
, “Enriched housing down-regulates the Toll-like receptor 2 response in the mouse brain after experimental stroke.”, Neurobiol Dis, vol. 66, pp. 66-73, 2014.
, “The morphological and molecular changes of brain cells exposed to direct current electric field stimulation.”, Int J Neuropsychopharmacol, vol. 18, no. 5, 2014.
, “Toll-like receptor expression in the blood and brain of patients and a mouse model of Parkinson's disease.”, Int J Neuropsychopharmacol, vol. 18, no. 6, 2014.
, “Ablation of proliferating cells in the CNS exacerbates motor neuron disease caused by mutant superoxide dismutase.”, PLoS One, vol. 7, no. 4, p. e34932, 2012.
, “Galectin-3 is required for resident microglia activation and proliferation in response to ischemic injury.”, J Neurosci, vol. 32, no. 30, pp. 10383-95, 2012.
, “Toll-like receptor 2 deficiency leads to delayed exacerbation of ischemic injury.”, J Neuroinflammation, vol. 9, p. 191, 2012.
, “Treatment with minocycline after disease onset alters astrocyte reactivity and increases microgliosis in SOD1 mutant mice.”, Exp Neurol, vol. 228, no. 1, pp. 69-79, 2011.
, “Extracellular mutant SOD1 induces microglial-mediated motoneuron injury.”, Glia, vol. 58, no. 2, pp. 231-43, 2010.
, “Lipopolysaccharide-QD micelles induce marked induction of TLR2 and lipid droplet accumulation in olfactory bulb microglia.”, Mol Pharm, vol. 7, no. 4, pp. 1183-94, 2010.
, “Microglial response to gold nanoparticles.”, ACS Nano, vol. 4, no. 5, pp. 2595-606, 2010.
, “Macrophage colony stimulating factor (M-CSF) exacerbates ALS disease in a mouse model through altered responses of microglia expressing mutant superoxide dismutase.”, Exp Neurol, vol. 220, no. 2, pp. 267-75, 2009.
, “Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase.”, J Neurosci, vol. 28, no. 41, pp. 10234-44, 2008.
, “Differential neuroprotective effects of a minocycline-based drug cocktail in transient and permanent focal cerebral ischemia.”, Exp Neurol, vol. 204, no. 1, pp. 433-42, 2007.
, “Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain.”, J Neurosci, vol. 27, no. 10, pp. 2596-605, 2007.
, “Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease.”, Neuron, vol. 49, no. 4, pp. 489-502, 2006.
, “Inflammation in ischemic brain injury: timing is important.”, Crit Rev Neurobiol, vol. 18, no. 1-2, pp. 145-57, 2006.
, “Mouse model for ablation of proliferating microglia in acute CNS injuries.”, Glia, vol. 53, no. 3, pp. 331-7, 2006.
, “Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis.”, J Neurosci, vol. 24, no. 6, pp. 1340-9, 2004.
, “Efficient three-drug cocktail for disease induced by mutant superoxide dismutase.”, Ann Neurol, vol. 53, no. 4, pp. 429-36, 2003.
, “Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration.”, Ann Neurol, vol. 54, no. 5, pp. 599-604, 2003.
, “Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis.”, Neurobiol Dis, vol. 10, no. 3, pp. 268-78, 2002.
